Canadian Diabetes & Endocrinology Today

Articles

• 

  Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?

  Ronald M. Goldenberg, MD, FRCPC, FACE

  5–9

  • PDF (en)
• 

  Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring

  Jagoda Kissock, MD

  10–16

  • PDF (en)
• 

  Anabolic Androgenic Steroids: No Longer on the Fringes of Endocrinology

  Adam Millar, MD, MScCH, FRCPC

  17–24

  • PDF (en)
• 

  To Hold or Not to Hold? Periprocedural Management of Glucagon-like Peptide-1 Receptor‑based Agonists (GLP‑1ra) in Patients with Diabetes and Obesity

  Tayyab S. Khan, MD

  26–34

  • PDF (en)
• 

  Androgenetic Alopecia: Pathogenesis, Evaluation, and Management

  Anastasiya Muntyanu, MD, PhD, FRCPC, FAAD

  35–42

  • PDF (en)